← All companies

ALGS

Aligos Therapeutics, Inc.

ALGS Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$4.60

+0.37 +8.75%

Key statistics

from XBRL data in SEC filings

Market cap

$47.9M

Revenue (TTM)

$4.71M

Net income (TTM)

-$90.3M

EPS (TTM)

$-2.55

P/E ratio

—

Dividend yield

—

Free cash flow

-$82.6M

Cash

$30.0M

Total assets

$64.6M

Gross margin

—

52-week range

$3.98 – $13.69

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change; Shareholder vote results Jun 26, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Entered a material agreement Apr 21, 2026 8-K Other events Apr 14, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release) Mar 5, 2026 8-K Director or officer change Feb 4, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 26, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 10-K Fiscal year ended 2024-12-31 Mar 10, 2025 8-K Results of operations (earnings release) Mar 10, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Feb 12, 2025 8-K Director or officer change Feb 3, 2025 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Other events Sep 5, 2024 8-K Modified rights of security holders; Amended charter or bylaws Aug 19, 2024 8-K Director or officer change Aug 8, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 28, 2024 8-K Delisting notice or listing-rule failure May 31, 2024 8-K Delisting notice or listing-rule failure; Director or officer change May 22, 2024 8-K Director or officer change May 15, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 10-K Fiscal year ended 2023-12-31 Mar 12, 2024 8-K Results of operations (earnings release) Mar 12, 2024 8-K Director or officer change Feb 28, 2024 8-K Other events Jan 25, 2024 8-K Director or officer change Nov 22, 2023 8-K Director or officer change Nov 15, 2023 10-Q Quarter ended 2023-09-30 Nov 2, 2023 8-K Results of operations (earnings release) Nov 2, 2023